| # | Drug | Count |
|---|---|---|
| 0 | METHOTREXATE SODIUM | 436 |
| 1 | ADALIMUMAB | 394 |
| 2 | METHOTREXATE | 381 |
| 3 | ASPIRIN | 359 |
| 4 | PREDNISONE | 359 |
| 5 | ACETAMINOPHEN | 352 |
| 6 | ONABOTULINUMTOXINA | 344 |
| 7 | ASPIRIN 325 MG | 341 |
| 8 | ASPIRIN 81 MG | 341 |
| 9 | OMEPRAZOLE MAGNESIUM | 313 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | SERTACONAZOLE NITRATE | 6 | 0.0370 |
| 1 | TRIHEXYPHENIDYL HYDROCHLORIDE | 32 | 0.0314 |
| 2 | CILTACABTAGENE AUTOLEUCEL | 175 | 0.0267 |
| 3 | SODIUM THIOSULFATE | 10 | 0.0179 |
| 4 | VANDETANIB | 25 | 0.0138 |
| 5 | DEOXYCHOLIC ACID | 30 | 0.0129 |
| 6 | BOTULINUM TOXIN TYPE A | 125 | 0.0098 |
| 7 | CARBAMIDE PEROXIDE | 4 | 0.0090 |
| 8 | TOFERSEN | 5 | 0.0088 |
| 9 | EFGARTIGIMOD ALFA AND HYALURONIDASE (HUMAN RECOMBINANT) | 4 | 0.0082 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 879 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 798 |
| 2 | Acetylcholine Release Inhibitor [EPC] | 492 |
| 3 | Neuromuscular Blocker [EPC] | 492 |
| 4 | Proton Pump Inhibitor [EPC] | 472 |
| 5 | Benzodiazepine [EPC] | 408 |
| 6 | Folate Analog Metabolic Inhibitor [EPC] | 388 |
| 7 | Platelet Aggregation Inhibitor [EPC] | 364 |
| 8 | Tumor Necrosis Factor Blocker [EPC] | 349 |
| 9 | Atypical Antipsychotic [EPC] | 333 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 32 | 0.0465 |
| 1 | Cytolytic Agent [EPC] | 30 | 0.0129 |
| 2 | Provitamin D2 Compound [EPC] | 237 | 0.0080 |
| 3 | Protease Activator [EPC] | 1 | 0.0078 |
| 4 | CD123 Interaction [EPC] | 4 | 0.0074 |
| 5 | Guanylate Cyclase-C Agonist [EPC] | 13 | 0.0063 |
| 6 | CD38-directed Cytolytic Antibody [EPC] | 36 | 0.0062 |
| 7 | Endoglycosidase [EPC] | 11 | 0.0059 |
| 8 | Acetylcholine Release Inhibitor [EPC] | 492 | 0.0050 |
| 9 | Interleukin-17A Antagonist [EPC] | 151 | 0.0040 |